Australia - English - Department of Health (Therapeutic Goods Administration)

omegapharm - cefepime -

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

vesalius pharma, s.a. - cefepime (hidrocloruro estÉril) - cefepime (hidrocloruro estÉril) ....1,00 g

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

shandong luoxin pharmaceutical group stock co.,ltd - cefepime - cefepime....1.0 g

Kenya - English - Pharmacy and Poisons Board

cefixime - tablet - 400mg - cefixime

United States - English - NLM (National Library of Medicine)

lupin limited - cefixime (unii: 97i1c92e55) (cefixime anhydrous - unii:xz7bg04gjx) - cefixime anhydrous 400 mg

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - cefixime (unii: 97i1c92e55) (cefixime anhydrous - unii:xz7bg04gjx) - cefixime anhydrous 400 mg

United States - English - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - cefixime (unii: 97i1c92e55) (cefixime anhydrous - unii:xz7bg04gjx) - cefixime anhydrous 400 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

cefepime hydrochloride monohydrate -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

aft pharmaceuticals (se asia) sdn bhd - cefepime hydrochloride monohydrate -

United States - English - NLM (National Library of Medicine)

hospira, inc. - cefepime hydrochloride (unii: i8x1o0607p) (cefepime - unii:807pw4vqe3) - cefepime 1 g - maxipime is indicated in the treatment of pneumonia (moderate to severe) caused by susceptible strains of streptococcus pneumoniae , including cases associated with concurrent bacteremia, pseudomonas aeruginosa , klebsiella pneumoniae , or enterobacter species. maxipime as monotherapy is indicated for empiric treatment of febrile neutropenic patients. in patients at high risk for severe infection (including patients with a history of recent bone marrow transplantation, with hypotension at presentation, with an underlying hematologic malignancy, or with severe or prolonged neutropenia), antimicrobial monotherapy may not be appropriate. insufficient data exist to support the efficacy of cefepime monotherapy in such patients [see clinical studies (14.1) ]. maxipime is indicated in the treatment of uncomplicated and complicated urinary tract infections (including pyelonephritis) caused by susceptible isolates of escherichia coli or klebsiella pneumoniae , when the infection is severe, or caused by escherichia c